scientistlive.com11 天
Merging technologies to cure prion diseases
To receive our free weekly NewsBrief please enter your email address below: ...
scientistlive.com12 天
Sino Biological: Engineering the tools to outsmart HIV
To receive our free weekly NewsBrief please enter your email address below: ...
scientistlive.com29 天
Kinase inhibitors: Overcoming resistance and enhancing clinical outcomes
Figure 1. Abnormal activation of protein tyrosine kinases (PTKs) in tumours. Proper PTK activation and inactivation are crucial for normal cellular function. Aberrant PTK activation is mediated by ...